Suivre
Max LAFONTAN
Max LAFONTAN
Director of Research, French Institute of Health and Medical Research (Inserm), Toulouse
Adresse e-mail validée de inserm.fr
Titre
Citée par
Citée par
Année
Leptin, the product of Ob gene, promotes angiogenesis
A Bouloumié, HCA Drexler, M Lafontan, R Busse
Circulation research 83 (10), 1059-1066, 1998
10281998
Lipolysis and lipid mobilization in human adipose tissue
M Lafontan, D Langin
Progress in lipid research 48 (5), 275-297, 2009
9922009
Leptin induces oxidative stress in human endothelial cells
A Bouloumié, T Marumo, M Lafontan, R Busse
The FASEB Journal 13 (10), 1231-1238, 1999
9881999
Fat cell adrenergic receptors and the control of white and brown fat cell function
M Lafontan, M Berlan
Journal of lipid research 34 (7), 1057-1091, 1993
8441993
Natriuretic peptides: a new lipolytic pathway in human adipocytes
C Sengenès, M Berlan, I de Glisezinski, MAX Lafontan, J Galitzky
The FASEB Journal 14 (10), 1345-1351, 2000
6412000
Physical activity and exercise in the regulation of human adipose tissue physiology
D Thompson, F Karpe, M Lafontan, K Frayn
Physiological reviews, 2012
4972012
Remodeling phenotype of human subcutaneous adipose tissue macrophages
V Bourlier, A Zakaroff-Girard, A Miranville, S De Barros, M Maumus, ...
Circulation 117 (6), 806-815, 2008
4502008
Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation
A Bouloumié, C Sengenes, G Portolan, J Galitzky, M Lafontan
Diabetes 50 (9), 2080-2086, 2001
4292001
Do regional differences in adipocyte biology provide new pathophysiological insights?
M Lafontan, M Berlan
Trends in Pharmacological Sciences 24 (6), 276-283, 2003
3802003
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity
C Duffaut, J Galitzky, M Lafontan, A Bouloumié
Biochemical and biophysical research communications 384 (4), 482-485, 2009
3752009
Sugar-sweetened beverages and weight gain in children and adults: a systematic review from 2013 to 2015 and a comparison with previous studies
M Luger, M Lafontan, M Bes-Rastrollo, E Winzer, V Yumuk, ...
Obesity facts 10 (6), 674-693, 2018
3562018
Heterogeneous distribution of beta and alpha‐2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences
P Mauriege, J Galitzky, M Berlan, M Lafontan
European journal of clinical investigation 17 (2), 156-165, 1987
3221987
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes
C Sengenes, A Bouloumié, H Hauner, M Berlan, R Busse, M Lafontan, ...
Journal of Biological Chemistry 278 (49), 48617-48626, 2003
3182003
Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence
A Villaret, J Galitzky, P Decaunes, D Esteve, MA Marques, C Sengenes, ...
Diabetes 59 (11), 2755-2763, 2010
2962010
Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators
C Duffaut, A Zakaroff-Girard, V Bourlier, P Decaunes, M Maumus, ...
Arteriosclerosis, thrombosis, and vascular biology 29 (10), 1608-1614, 2009
2792009
Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes
K Lolmede, V Durand de Saint Front, J Galitzky, M Lafontan, A Bouloumie
International journal of obesity 27 (10), 1187-1195, 2003
2792003
Control of lipolysis by natriuretic peptides and cyclic GMP
M Lafontan, C Moro, M Berlan, F Crampes, C Sengenes, J Galitzky
Trends in Endocrinology & Metabolism 19 (4), 130-137, 2008
2742008
Fat cells: afferent and efferent messages define new approaches to treat obesity
M Lafontan
Annu. Rev. Pharmacol. Toxicol. 45, 119-146, 2005
2642005
Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species
D Langin, MP Portillo, JS Saulnier-Blache, M Lafontan
European journal of pharmacology 199 (3), 291-301, 1991
2521991
Adipose tissue and adipocyte dysregulation
M Lafontan
Diabetes & metabolism 40 (1), 16-28, 2014
2512014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20